Printer Friendly

Browse Mycophenolate mofetil topic

Subtopics (11)

 

Articles

1-34 out of 34 article(s)
Title Author Type Date Words
Drugs of the l-compositions for treating malignancies (leuprorelin, triptorelin, mycophenolate mofetil, fingolimod, etanercept). Apr 21, 2015 124
Tablet/capsule mycophenolate mofetil - 500 mg. Apr 8, 2015 157
Supply of Medicines, inj.paclitaxel 260mg, tab mycophenolate mofetil 500mg, colostomy bag no.13860, belt with clip 4 inch size,. Apr 3, 2015 115
supply of Medicines, inj infliximab 100mg, tab pentasa 500mg, tab mycophenolate mofetil 500mg, tab tacrolimus0.5 mg. Apr 3, 2015 109
Mycophenolate mofetil 500mg tab in strip brand cellcept 500 mg. Mar 31, 2015 472
Supply Of Medicines, Tab Mycophenolate Mofetil 500mg, Tab Pramipexole 1mg, Tab Syndopa Plus, Tab Syndopa CR, Cap Calcitriol 0.25mcg, Tab Hypophos 667mg, Tab Asunra 400mg (Novartis make), Cap Hydroxyur. Mar 18, 2015 114
1)cellcept 500mg tab qty: 6000 null 8)null qty: null null. Feb 28, 2015 107
Tab. mycophenolate mofetil 500 mg. Feb 27, 2015 101
DIAMOND (ADVAGRAF Studied in Combination With Mycophenolate Mofetil (MMF) and Basiliximabin Liver Transplantation) Study Provides Insights Into Kidney Function and the Prophylaxis of Organ Rejection in Liver Transplant Patients. Feb 23, 2015 1138
Tab mycophenolate mofetil 500mg in strip packing. Jun 16, 2014 174
Tab. mycophenolate mofetil 250mg in strip packing . 60625 tabs./caps. Jun 3, 2014 180
Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Gorgan, Maria; Bockorny, Bruno; Lawlor, Michael; Volpe, John; Fiel-Gan, Mary Report Nov 1, 2013 2553
Japan : Drug Application Filed for Additional Form of Immunosuppressant, a CellceptEe Powder for Oral Suspension 32%a. Aug 23, 2013 217
Identification of cause of posttransplant cachexia by PCR. Guitard, Joelle; Edouard, Sophie; Lepidi, Hubert; Segonds, Christine; Grare, Marion; Ranty-Quintyn, Letter to the editor Aug 1, 2012 1503
Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting. Clinical report Apr 14, 2011 1006
Potential of immunosuppressive agents in cerebral ischaemia. Gupta, Yogendra Kumar; Chauhan, Anjali Report Jan 1, 2011 7745
Trials and tribulations in systemic lupus erythematosus. Wofsy, David Report Jul 1, 2010 2422
GlaxoSmithKline Plc and US regulators said on Thursday they had notified healthcare professionals that a type of anemia has been reported in some patients treated with transplant drug Myfortic. Brief article Sep 14, 2009 143
Sandoz launches generic version of CellCept. May 1, 2009 90
New lupus drugs remain elusive after 50 years. Walsh, Nancy Report Mar 15, 2009 973
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint. Mar 11, 2009 1374
Mycophenolic acid metabolite levels in pediatric liver transplantation: correlation with a limited sampling strategy. Attard, Thomas M.; Dhawan, Anil; Tredger, J. Michael; Conner, Kim; Kling, Karen; Colombani, Paul; Th Clinical report Jun 1, 2008 3641
Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells. Bremer, Sara; Rootwelt, Helge; Bergan, Stein Jun 1, 2007 4437
Oral mycophenolate mofetil looks promising for lupus nephritis. Worcester, Sharon Jan 1, 2006 443
Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Streit, Frank; Shipkova, Maria; Armstrong, Victor William; Oellerich, Michael Jan 1, 2004 5418
Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil. (Case Report). Lindsley, Carol B. Jul 1, 2003 1796
Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Pawinski, Tomasz; Hale, Mike; Korecka, Magda; Fitzsimmons, William E.; Shaw, Leslie M. Sep 1, 2002 6364
Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil. Shipkova, Maria; Armstrong, Victor William; Kiehl, Michael G.; Niedmann, Paul Dieter; Schutz, Ekkeha Aug 1, 2001 2874
Prodrug metabolites: implications for therapeutic drug monitoring. Oellerich, Michael; Armstrong, Victor W. May 1, 2001 1615
Assessment of mycophenolic acid-induced immunosuppression: a new approach. Millan, Olga; Oppenheimer, Federic; Brunet, Merce; Vilardell, Jordi; Rojo, Isabel; Vives, Jordi; Mar Clinical report Sep 1, 2000 5560
Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Schutz, Ekkehard; Shipkova, Maria; Armstrong, Victor W.; Wieland, Eberhard; Oellerich, Michael Mar 1, 1999 2181
Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma. Shipkova, Maria; Armstrong, Victor William; Schneider, Tanja; Niedmann, Paul Dieter; Schutz, Ekkehar Jan 1, 1999 2123
Prospective investigations of concentration--clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring. Shaw, Leslie M.; Kaplan, Bruce; Brayman, Kenneth L. Clinical report Feb 1, 1998 5776
IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Griesmacher, Andrea; Weigel, Gunter; Seebacher, Gernot; Muller, Mathias M. Dec 1, 1997 4287

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters